07 / Work With Us
We are enrolling clinical sites, building hospital partnerships, and speaking with investors ahead of our FDA 510(k) submission in Q3 2026.
Enrol your institution in our Phase III trials and gain early device access for your patients.
Series B round open. Contact our BD team for data room access and management meetings.
OEM licensing, co-development agreements, and hospital procurement programmes are available.
We respond within 1 business day. Your data is handled under our Privacy Policy.